Bonn Team Converts 80-Year-Old Blood Cells Into Neural Stem Cells With Epigenetic Age Below 20

A study published this month in the journal Aging Cell reports that researchers at the University Hospital of Bonn and the University of Bonn converted blood-cell precursors from an 80-year-old donor into neural stem cells whose epigenetic age, measured by DNA methylation clocks, registered below 20 years. That's a molecular reversal of more than six decades, in a dish, over roughly 100 days.

The paper's first authors describe a technique that sidesteps the standard two-step reprogramming route. Most prior work converts mature cells into induced pluripotent stem cells first, then coaxes those toward a target cell type. That rapid detour through pluripotency tends to compress and obscure the rejuvenation event, making it hard to study. According to a statement reviewed by the University of Bonn's Medical Faculty, the Bonn team skipped the pluripotent stage entirely. They took erythroid progenitor cells, which are immature red blood cell precursors, and drove them directly into induced neural stem cells using transcription factor cocktails that rewire which genes a cell reads.

Because the conversion was slow and direct, the researchers could watch the epigenetic clock wind backwards in near-real time. The study included donor cells from 15 people ranging from newborn to 101 years old, giving the team a spectrum of starting ages to work with. The resulting neural stem cells were capable of differentiating further into neurons, and epigenetic clock measurements confirmed the dramatic age shift. The reprogramming reset epigenetic markers substantially without altering the underlying DNA sequence itself.

Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn and a corresponding author on the paper, framed the utility in terms of disease modeling rather than clinical application. Age is the dominant risk factor for neurodegeneration, he noted in materials reviewed by news-medical.net, and having a laboratory model that captures genuine age-related molecular states in neurons could sharpen the study of conditions like Alzheimer's disease.

That framing is worth holding onto, because the popular coverage of this study has already outpaced what the data can support. The paper describes a laboratory model. The sample is small, the donor count is 15, and every result was generated in vitro. Nothing in the published findings tells us whether epigenetically younger neurons behave functionally younger, whether the reset persists during long-term culture, or whether any of this translates to a living system. The study doesn't claim otherwise, but the press release ecosystem tends to quietly drop those caveats.

What the paper does establish, according to reporting on the Aging Cell publication, is a reproducible direct conversion protocol that makes the rejuvenation process observable step by step. That's genuinely useful for basic science, specifically for researchers who want to isolate what drives age-associated changes in neural tissue and test whether those changes are causally relevant to disease.

The study, titled 'Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells,' was authored by Lea Jessica Berg, Julia Franzen, Andreas Buness and colleagues. The DOI is 10.1111/acel.70751. Replication in independent labs, functional characterization of the reprogrammed cells, and in vivo work are the logical next steps before the findings carry clinical weight.

Sources cited:
- Aging Cell (Berg et al., 2026) (https://onlinelibrary.wiley.com/doi/10.1111/acel.70751)
- University of Bonn Medical Faculty announcement (https://www.medfak.uni-bonn.de/en/research/infrastructure/news/researchers-transform-old-blood-cells-into-young-brain-cells)
- News-Medical.net (https://www.news-medical.net/news/20261009/Bonn-researchers-successfully-rejuvenate-human-cells-in-a-test-tube.aspx)
- ScienceDaily (University of Bonn) (https://www.sciencedaily.com/releases/2026/10/261020085013.htm)
- The Debrief (https://thedebrief.org/a-new-breakthrough-in-cellular-reprogramming-reverses-60-years-of-molecular-aging/)